Current Bladder Dysfunction Reports

, Volume 9, Issue 2, pp 96–101

Transition of Care and Treatment of the Adult Spina Bifida Patient

Voiding Dysfunction Evaluation (C Gomez, Section Editor)


Adult spina bifida patients are an underserved population in terms of healthcare in general and urologic care in particular. These patients have unique urologic issues arising from the underlying disease process as well as prior treatments. Multidisciplinary clinics deliver coordinated care in a limited number of locations and many patients receive care in their local community. In an effort to improve patient care, this article will empower the general adult urologist to care for the urologic needs of adult spina bifida patients and educate the reader about the fundamentals of transitional urologic care.


Spina bifida Transitional care Treatment of adult spina bifida Neurogenic bladder Urinary incontinence Urodynamics Urinary tract reconstruction Voiding dysfunction Myelodysplasia 


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Parker SE, Mai CT, Canfield MA, Rickard R, Wang Y, Meyer RE, et al. Updated national birth prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Def Res Part A Clin Mol Teratol. 2010;88(12):1008–16. doi:10.1002/bdra.20735.CrossRefGoogle Scholar
  2. 2.•
    Williams LJ, Mai CT, Edmonds LD, Shaw GM, Kirby RS, Hobbs CA, et al. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology. 2002;66(1):33–9. doi:10.1002/tera.10060. Demonstrates the effect of folic acid fortification on reducing the incidence of spina bifida in USA.
  3. 3.
    Bowman RM, McLone DG, Grant JA, Tomita T, Ito JA. Spina bifida outcome: A 25-year prospective. Pediatr Neurosurg. 2001;34(3):114–20.PubMedCrossRefGoogle Scholar
  4. 4.
    Oakeshott P, Hunt GM, Poulton A, Reid F. Expectation of life and unexpected death in open spina bifida: A 40-year complete, non-selective, longitudinal cohort study. Dev Med Child Neurol. 2010;52(8):749–53. doi:10.1111/j.1469-8749.2009.03543.x.PubMedCrossRefGoogle Scholar
  5. 5.
    Clinics, Spina Bifida Association, Retrieved January 2, 2014, from
  6. 6.
    Sawyer SM, Macnee S. Transition to adult health care for adolescents with spina bifida: Research issues. Dev Disabil Res Rev. 2010;16(1):60–5. doi:10.1002/ddrr.98.PubMedCrossRefGoogle Scholar
  7. 7.
    Dicianno BE, Wilson R. Hospitalizations of adults with spina bifida and congenital spinal cord anomalies. Arch Phys Med Rehabil. 2010;91(4):529–35. doi:10.1016/j.apmr.2009.11.023.PubMedCrossRefGoogle Scholar
  8. 8.
    Lawrenson R, Wyndaele JJ, Vlachonikolis I, Farmer C, Glickman S. Renal failure in patients with neurogenic lower urinary tract dysfunction. Neuroepidemiology. 2001;20(2):138–43.PubMedCrossRefGoogle Scholar
  9. 9.
    McDonnell GV, McCann JP. Why do adults with spina bifida and hydrocephalus die? A clinic-based study. Eur J Pediatr Surg: Off J Austrian Assoc Pediatr Surg [Et Al] = Zeitschrift Fur Kinderchirurgie. 2000;10 Suppl 1:31–2. doi:10.1055/s-2008-1072411.CrossRefGoogle Scholar
  10. 10.••
    McGuire EJ, Woodside JR, Borden TA, Weiss RM. Prognostic value of urodynamic testing in myelodysplastic patients. J Urology. 1981;126(2):205–209. Seminal work which established that detrusor leak point pressure greater than 40 cm H 2 0 can lead to upper urinary tract deterioration in patients with spina bifida. Google Scholar
  11. 11.
    Peeker R, Damber JE, Hjalmas K, Sjodin JG, von Zweigbergk M. The urological fate of young adults with myelomeningocele: A three decade follow-up study. Eur Urol. 1997;32(2):213–7.PubMedGoogle Scholar
  12. 12.
    Persun ML, Ginsberg PC, Harmon JD, Harkaway RC. Role of urologic evaluation in the adult spina bifida patient. Urol Int. 1999;62(4):205–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Thorup J, Biering-Sorensen F, Cortes D. Urological outcome after myelomeningocele: 20 years of follow-up. BJU Int. 2011;107(6):994–9. doi:10.1111/j.1464-410X.2010.09681.x.PubMedCrossRefGoogle Scholar
  14. 14.
    Hernandez RD, Hurwitz RS, Foote JE, Zimmern PE, Leach GE. Nonsurgical management of threatened upper urinary tracts and incontinence in children with myelomeningocele. J Urol. 1994;152(5 Pt 1):1582–5.PubMedGoogle Scholar
  15. 15.
    Almodhen F, Capolicchio JP, Jednak R, El Sherbiny M. Postpubertal urodynamic and upper urinary tract changes in children with conservatively treated myelomeningocele. J Urol. 2007;178(4 Pt 1):1479–82. doi:10.1016/j.juro.2007.05.171.PubMedCrossRefGoogle Scholar
  16. 16.
    Moore C, Kogan BA, Parekh A. Impact of urinary incontinence on self-concept in children with spina bifida. J Urol. 2004;171(4):1659–62. doi:10.1097/01.ju.0000117865.98229.e5.PubMedGoogle Scholar
  17. 17.
    Lemelle JL, Guillemin F, Aubert D, Guys JM, Lottmann H, Lortat-Jacob S, et al. A multicenter evaluation of urinary incontinence management and outcome in spina bifida. J Urol. 2006;175(1):208–12. doi:10.1016/S0022-5347(05)00055-8.PubMedGoogle Scholar
  18. 18.
    Vainrib M, Reyblat P, Ginsberg DA. Differences in urodynamic study variables in adult patients with neurogenic bladder and myelomeningocele before and after augmentation enterocystoplasty. Neurourol Urodyn. 2013;32(3):250–3. doi:10.1002/nau.22304; 10.1002/nau.22304.PubMedCrossRefGoogle Scholar
  19. 19.
    Verhoef M, Lurvink M, Barf HA, Post MW, van Asbeck FW, Gooskens RH, et al. High prevalence of incontinence among young adults with spina bifida: Description, prediction and problem perception. Spinal Cord. 2005;43(6):331–40. doi:10.1038/ Scholar
  20. 20.
    George TM, Fagan LH. Adult tethered cord syndrome in patients with postrepair myelomeningocele: An evidence-based outcome study. J Neurosurg. 2005;102(2 Suppl):150–6. doi:10.3171/jns.2005.102.2.0150.PubMedCrossRefGoogle Scholar
  21. 21.
    Gatti C, Del Rossi C, Ferrari A, Casolari E, Casadio G, Scire G. Predictors of successful sexual partnering of adults with spina bifida. J Urol. 2009;182(4 Suppl):1911–6. doi:10.1016/j.juro.2009.02.065.PubMedCrossRefGoogle Scholar
  22. 22.
    Lassmann J, Garibay Gonzalez F, Melchionni JB, Pasquariello Jr PS, Snyder 3rd HM. Sexual function in adult patients with spina bifida and its impact on quality of life. J Urol. 2007;178(4 Pt 2):1611–4. doi:10.1016/j.juro.2007.03.162.PubMedCrossRefGoogle Scholar
  23. 23.
    Natarajan V, Kapur D, Sharma S, Singh G. Pregnancy in patients with spina bifida and urinary diversion. Int Urogynecol J Pelvic Floor Dysfunct. 2002;13(6):383–5. doi:10.1007/s001920200085.PubMedCrossRefGoogle Scholar
  24. 24.
    Gros DA, Thakkar RN, Lakshmanan Y, Ruffing V, Kinsman SL, Docimo SG. Urolithiasis in spina bifida. Eur J Pediatr Surg: Off J Austrian Assoc Pediatr Surg [Et Al] = Zeitschrift Fur Kinderchirurgie. 1998;8 Suppl 1:68–9.Google Scholar
  25. 25.
    Raj GV, Bennett RT, Preminger GM, King LR, Wiener JS. The incidence of nephrolithiasis in patients with spinal neural tube defects. J Urol. 1999;162(3 Pt 2):1238–42.PubMedCrossRefGoogle Scholar
  26. 26.
    Veenboer PW, Ruud Bosch JL, van Asbeck FW, de Kort LM. Urolithiasis in adult spina bifida patients: Study in 260 patients and discussion of the literature. Int Urol Nephrol. 2013;45(3):695–702. doi:10.1007/s11255-013-0445-8.PubMedCrossRefGoogle Scholar
  27. 27.
    Alsinnawi M, Torreggiani WC, Flynn R, McDermott TE, Grainger R, Thornhill JA. Percutaneous nephrolithotomy in adult patients with spina bifida, severe spinal deformity and large renal stones. Ir J Med Sci. 2013;182(3):357–61. doi:10.1007/s11845-012-0888-4.PubMedCrossRefGoogle Scholar
  28. 28.
    Mourtzinos A, Stoffel JT. Management goals for the spina bifida neurogenic bladder: A review from infancy to adulthood. Urol Clin N Am. 2010;37(4):527–35. doi:10.1016/j.ucl.2010.06.009.CrossRefGoogle Scholar
  29. 29.
    Metcalfe PD, Casale AJ, Kaefer MA, Misseri R, Dussinger AM, Meldrum KK, et al. Spontaneous bladder perforations: A report of 500 augmentations in children and analysis of risk. J Urol. 2006;175(4):1466–70. doi:10.1016/S0022-5347(05)00672-5. discussion 1470-1.PubMedGoogle Scholar
  30. 30.
    DeFoor W, Tackett L, Minevich E, Wacksman J, Sheldon C. Risk factors for spontaneous bladder perforation after augmentation cystoplasty. Urology. 2003;62(4):737–41.PubMedCrossRefGoogle Scholar
  31. 31.
    Ehdaie B, Mason MD, Gray M, Peters CA, Corbett ST. Bladder perforation in augmentation cystoplasty during urodynamic investigation: A case report and review of the literature. J Pediatr Urol. 2013;9(2):e102–6. doi:10.1016/j.jpurol.2012.11.013.PubMedCrossRefGoogle Scholar
  32. 32.
    Van der Aa F, Joniau S, De Baets K, De Ridder D. Continent catheterizable vesicostomy in an adult population: Success at high costs. Neurourol Urodyn. 2009;28(6):487–91. doi:10.1002/nau.20699.PubMedCrossRefGoogle Scholar
  33. 33.
    Chulamorkodt NN, Estrada CR, Chaviano AH. Continent urinary diversion: 10-year experience of Shriners Hospitals for Children in Chicago. J Spinal Cord Med. 2004;27 Suppl 1:S84–7.PubMedGoogle Scholar
  34. 34.
    Pham-Huy A, Leonard M, Lepage N, Halton J, Filler G. Measuring glomerular filtration rate with cystatin C and beta-trace protein in children with spina bifida. J Urol. 2003;169(6):2312–5. doi:10.1097/01.ju.0000060205.23406.13.PubMedCrossRefGoogle Scholar
  35. 35.
    Shlipak MG, Matsushita K, Arnlov J, Inker LA, Katz R, Polkinghorne KR, et al. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med. 2013;369(10):932–43. doi:10.1056/NEJMoa1214234.PubMedCrossRefGoogle Scholar
  36. 36.
    Abrahamsson K, Jodal U, Sixt R, Olsson I, Sillen U. Estimation of renal function in children and adolescents with spinal dysraphism. J Urol. 2008;179(6):2407–9. doi:10.1016/j.juro.2008.01.167.PubMedCrossRefGoogle Scholar
  37. 37.••
    Stohrer M, Blok B, Castro-Diaz D, Chartier-Kastler E, Del Popolo G, Kramer G, et al. EAU guidelines on neurogenic lower urinary tract dysfunction. Eur Urol. 2009;56(1):81–8. doi:10.1016/j.eururo.2009.04.028. Comprehensive guidelines from European Association of Urology on evaluation and management of neurogenic lower urinary tract dysfunction, including but not limited to spina bifida.
  38. 38.
    Soergel TM, Cain MP, Misseri R, Gardner TA, Koch MO, Rink RC. Transitional cell carcinoma of the bladder following augmentation cystoplasty for the neuropathic bladder. J Urol. 2004;172(4 Pt 2):1649–51.PubMedCrossRefGoogle Scholar
  39. 39.
    Higuchi TT, Fox JA, Husmann DA. Annual endoscopy and urine cytology for the surveillance of bladder tumors after enterocystoplasty for congenital bladder anomalies. J Urol. 2011;186(5):1791–5. doi:10.1016/j.juro.2011.07.028.PubMedCrossRefGoogle Scholar
  40. 40.
    Austin JC, Elliott S, Cooper CS. Patients with spina bifida and bladder cancer: Atypical presentation, advanced stage and poor survival. J Urol. 2007;178(3 Pt 1):798–801. doi:10.1016/j.juro.2007.05.055.Google Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Department of UrologyUniversity of MinnesotaMinneapolisUSA
  2. 2.Gillette Children’s Specialty HealthcareSaint PaulUSA

Personalised recommendations